Pages that link to "Q51750812"
Jump to navigation
Jump to search
The following pages link to Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study. (Q51750812):
Displaying 36 items.
- Risk factors for subsequent endocrine-related cancer in childhood cancer survivors (Q26745707) (← links)
- Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation (Q26827226) (← links)
- Thyroid nodules in pediatrics: which ones can be left alone, which ones must be investigated, when and how (Q26997448) (← links)
- Secondary solid cancer screening following hematopoietic cell transplantation (Q28088369) (← links)
- National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent Neoplasms (Q29248394) (← links)
- Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning (Q34568905) (← links)
- Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up (Q35184667) (← links)
- Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an update (Q35664284) (← links)
- Subsequent Malignant Neoplasms after Hematopoietic Cell Transplantation (Q35678455) (← links)
- Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: Diagnostic and therapeutic challenges (Q36266642) (← links)
- Secondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in Childhood (Q37055896) (← links)
- Solid cancers after allogeneic hematopoietic cell transplantation (Q37082013) (← links)
- Endocrinological late complications after hematopoietic SCT in children (Q37188477) (← links)
- Late thyroid complications in survivors of childhood acute leukemia. An L.E.A. study (Q37237908) (← links)
- Late complications after hematopoietic stem cell transplantation (Q37810122) (← links)
- Secondary cancers following allogeneic haematopoietic cell transplantation in adults (Q37880254) (← links)
- Second Solid Tumors: Screening and Management Guidelines in Long-Term Survivors After Allogeneic Stem Cell Transplantation (Q37973495) (← links)
- Endocrine Complications in Long-Term Survivors After Allogeneic Stem Cell Transplant (Q37973504) (← links)
- Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies. (Q38628809) (← links)
- Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction (Q40217390) (← links)
- Endocrine late effects after total body irradiation in patients who received hematopoietic cell transplantation during childhood: a retrospective study from a single institution (Q43939973) (← links)
- Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study (Q44366982) (← links)
- Second cancer after total-body irradiation (TBI) in childhood (Q44824430) (← links)
- Allogeneic haematopoietic stem cell transplantation for infant acute lymphoblastic leukaemia with KMT2A (MLL) rearrangements: a retrospective study from the paediatric acute lymphoblastic leukaemia working group of the Japan Society for Haematopoiet (Q45806338) (← links)
- Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR). (Q45866746) (← links)
- Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters. (Q47959792) (← links)
- Thyroid dysfunction in adult hematopoietic cell transplant survivors: risks and outcomes (Q48095352) (← links)
- Second Malignancies after Hematopoietic Stem Cell Transplantation (Q50104242) (← links)
- Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy (Q50453982) (← links)
- Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT. (Q52964863) (← links)
- High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study. (Q53105653) (← links)
- Thyroid nodules and long-term follow-up among childhood cancer survivors who underwent hematopoietic stem cell transplantation. (Q54972139) (← links)
- Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients (Q64120765) (← links)
- Screening for differentiated thyroid cancer in selected populations (Q90571944) (← links)
- Long-term Effects of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia (Q90733679) (← links)
- Risk of Head and Neck Cancer in Patients With Prior Hematologic Malignant Tumors (Q91688305) (← links)